Source: Annual Congress 2006 - Early detection, diagnosis, staging and clinical features of lung cancer
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
V. G. Pischik, A. B. Zorin, V. M. Moiseenko, P. K. Yablonsky (Saint Petersburg, Russian Federation). Pulmonary hypertension and multiple pulmonary nodules caused by tumor of pulmonary artery (PA). Eur Respir J 2006; 28: Suppl. 50, 811

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis Source: Eur Respir J 2016; 47: 673-676 Year: 2016 Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Fatal dissection of the pulmonary artery in pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 181-185 Year: 2009 Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 The right ventricle (RV) in systemic sclerosis-associated pulmonary arterial hypertension (SSCPH) vs idiopathic pulmonary arterial hypertension (IPH): higher inflammatory status, no increase in interstitial fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 637-648 Year: 2004 Pulmonary vein stenosis mimicking interstitial lung disease Source: International Congress 2019 – CCC Pulmonary vascular diseases Year: 2019 Pulmonary vascular distensibility in pulmonary hypertension due to left heart disease Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary artery dilation and increased lung density in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Pulmonary vein banding-induced pulmonary venous congestion causes pulmonary hypertension in rats. Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Pulmonary hypertension in sickle cell disease Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease Year: 2007 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005